E4M_2.3: post-partum depression with M Marti-Castaner

Research output: Non-textual form › Sound/Visual production (digital) › Communication

Standard

E4M_2.3: post-partum depression with M Marti-Castaner. Di Nucci, Ezio (Content producer); Haase, Christoffer Bjerre (Content producer); Marti Castaner, Maria (Content producer). 2023. Spotify.

Research output: Non-textual form › Sound/Visual production (digital) › Communication

Harvard

Di Nucci, E, Haase, CB & Marti Castaner, M, E4M_2.3: post-partum depression with M Marti-Castaner, 2023, Sound/Visual production (digital), Spotify.

APA

Di Nucci, E. (Content producer), Haase, C. B. (Content producer), & Marti Castaner, M. (Content producer). (2023). E4M_2.3: post-partum depression with M Marti-Castaner. Sound/Visual production (digital), Spotify.

Vancouver

Di Nucci E (Content producer), Haase CB (Content producer), Marti Castaner M (Content producer). E4M_2.3: post-partum depression with M Marti-Castaner Spotify. 2023.

Author

Di Nucci, Ezio (Content producer) ; Haase, Christoffer Bjerre (Content producer) ; Marti Castaner, Maria (Content producer). / E4M_2.3: post-partum depression with M Marti-Castaner. [Sound/Visual production (digital)].

Bibtex

@misc{4bb1073717d04330a20558e67b69fa22,
title = "E4M_2.3: post-partum depression with M Marti-Castaner",
abstract = "For the first time in the long history of this podcast, Christoffer and ezio have a guest: Maria Marti-Castaner, a clinical psychologist and Assistant Professor in Public Mental Health at the University of Copenhagen, who joins them to discuss postpartum depression and whether meds can take down oppressive structures.The FDA has recently approved the first oral treatment indicated to treat postpartum depression. What{\textquoteright}s new about this medication? It seems to be faster-acting. In two clinical trials, women with severe depression experienced improved symptoms 15 days after taking the pill. Still, the long-term effects are unknown as well as its efficacy in mothers with moderate symptoms.While these are good news for women with severe postpartum depression, they also raise questions: when are we going to start addressing the social determinants of postpartum depression? Are pills moving us away from changing the structures that contribute to women{\textquoteright}s suffering? Or can pills be liberating?",
author = "{Di Nucci}, Ezio and Haase, {Christoffer Bjerre} and {Marti Castaner}, Maria",
note = "Ethics4Medics Podcast, Episode 2.3",
year = "2023",
language = "English",
publisher = "Spotify",

}

RIS

TY - ADVS

T1 - E4M_2.3: post-partum depression with M Marti-Castaner

A2 - Di Nucci, Ezio

A2 - Haase, Christoffer Bjerre

A2 - Marti Castaner, Maria

N1 - Ethics4Medics Podcast, Episode 2.3

PY - 2023

Y1 - 2023

N2 - For the first time in the long history of this podcast, Christoffer and ezio have a guest: Maria Marti-Castaner, a clinical psychologist and Assistant Professor in Public Mental Health at the University of Copenhagen, who joins them to discuss postpartum depression and whether meds can take down oppressive structures.The FDA has recently approved the first oral treatment indicated to treat postpartum depression. What’s new about this medication? It seems to be faster-acting. In two clinical trials, women with severe depression experienced improved symptoms 15 days after taking the pill. Still, the long-term effects are unknown as well as its efficacy in mothers with moderate symptoms.While these are good news for women with severe postpartum depression, they also raise questions: when are we going to start addressing the social determinants of postpartum depression? Are pills moving us away from changing the structures that contribute to women’s suffering? Or can pills be liberating?

AB - For the first time in the long history of this podcast, Christoffer and ezio have a guest: Maria Marti-Castaner, a clinical psychologist and Assistant Professor in Public Mental Health at the University of Copenhagen, who joins them to discuss postpartum depression and whether meds can take down oppressive structures.The FDA has recently approved the first oral treatment indicated to treat postpartum depression. What’s new about this medication? It seems to be faster-acting. In two clinical trials, women with severe depression experienced improved symptoms 15 days after taking the pill. Still, the long-term effects are unknown as well as its efficacy in mothers with moderate symptoms.While these are good news for women with severe postpartum depression, they also raise questions: when are we going to start addressing the social determinants of postpartum depression? Are pills moving us away from changing the structures that contribute to women’s suffering? Or can pills be liberating?

UR - https://open.spotify.com/episode/5XTpLhdc02OOnNe9QRn3sK

M3 - Sound/Visual production (digital)

PB - Spotify

ER -

ID: 370494466